[◀返回](./home.md)

# 合成大麻素类物质

| | |
|---|---|
| ![](/文件/Skull_and_crossbones_darktextred2.png) | **合成大麻素：超过 1,000 人住院，94 例死亡与三种类型有关**<br><br>多种合成大麻素都会带来严重的健康风险哦。仅 MDMB-FUBINACA 一种物质就与超过 1,000 例住院治疗和 40 例死亡有关，主要发生在俄罗斯和白俄罗斯呢。在整个欧洲，MDMB-CHMICA 和 5F-ADB 在 2014 年至 2017 年间共导致了 54 人死亡。 |

![](/文件/USMC-100201-M-3762C-001.jpg "一包 Spice 品牌的草本熏香。这里面含有合成大麻素，能产生类似大麻的效果呢。")

**合成大麻素类物质**（也常被称为**合成大麻**、**noids**、**草本熏香**、**K2** 或 **Spice** 嘛）是一类能够结合大麻素受体并产生类似[大麻](/药物/大麻.md)的[主观效应](/药效/主观效应索引.md)的化合物。大多数合成大麻素是[四氢大麻酚（THC）](/药物/四氢大麻酚（THC）.md)的类似物，THC 可是大麻中的主要活性成分呢，而像[大麻二酚（CBD）](/药物/大麻二酚（CBD）.md)这样没有精神活性的 cannabinoids 研究得就比较少啦。像 THC 一样，大多数合成大麻素也会结合大脑中相同的大麻素受体，而且经常作为合法的替代品出售哦。

合成大麻素通常被喷洒或浸泡在干草药中，让它们看起来更像大麻[\[1\]](#cite_note-1)，但纯粉末也可以在在线[研究用化学品](/文档/研究用化学品.md)市场上买到呢。它们通常通过[抽吸](/文档/给药途径.md)或[雾化](/文档/给药途径.md)的方式使用，以达到快速的[药效发作](/文档/药效时长.md)。当溶解在脂质中时，它们也具有[口服](/文档/给药途径.md)活性，这会显着增加[药效时长](/文档/药效时长.md)哦。大多数合成大麻素不溶于水，但溶于乙醇和脂质。

与[大麻](/药物/大麻.md)不同的是，长期滥用合成大麻素已[与多起死亡事件有关](/文档/药物分类/合成大麻素类物质.md#死亡案例)，并且总体上具有[更危险的副作用和毒性](/文档/药物分类/合成大麻素类物质.md#毒性和危害潜能)。因此，我们强烈不建议长时间或大剂量使用这些物质呢。此外，许多合成大麻素几乎没有人类研究数据，有些比其他的健康风险更严重。如果一定要使用这些物质，强烈建议采取[伤害减少措施](/文档/负责任的用药索引页.md)哦。

目录
--------

* [1 示例](#示例)
    + [1.1 草本混合物](#草本混合物)
    + [1.2 吲唑甲酰胺类](#吲唑甲酰胺类)
    + [1.3 吲哚甲酰胺类](#吲哚甲酰胺类)
    + [1.4 吲哚羧酸酯类](#吲哚羧酸酯类)
    + [1.5 萘甲酰吲哚类](#萘甲酰吲哚类)
    + [1.6 萘甲酰吲唑类](#萘甲酰吲唑类)
    + [1.7 四甲基环丙烷酰吲哚类](#四甲基环丙烷酰吲哚类)
    + [1.8 综合列表](#综合列表)
* [2 毒性和危害潜能](#毒性和危害潜能)
    + [2.1 死亡案例](#死亡案例)
    + [2.2 精神病](#精神病)
    + [2.3 毒性](#毒性)
    + [2.4 成瘾潜能](#成瘾潜能)
    + [2.5 危险的相互作用](#危险的相互作用)
* [3 另见](#另见)
* [4 外部链接](#外部链接)
* [5 参考文献](#参考文献)

示例
--------

![](/文件/Synthetic_cannabinoids.png "合成大麻素的比较")

### 草本混合物

流行的草本混合物包括 K2[\[2\]](#cite_note-2) 和 Spice[\[3\]](#cite_note-3)，这两个都是用于任何合成大麻素产品的通用商标名称呢。合成大麻素通常作为“草本熏香”和“草本吸烟混合物”销售。预先混合的品牌混合物（如 Spice 和 K2）比纯粉末更危险哦，因为具体的化学成分和剂量通常没有列出，而且粉末密度不均可能导致局部浓度过高，从而引发[药物过量](/文档/药物过量.md)呢。

许多人因为相信它们在效力、[危害潜能](/文档/药物分类/合成大麻素类物质.md#毒性和危害潜能)和效果上与大麻相当而住院或遭受负面症状。事实可不是这样呢，应该避免使用这些混合物，转而选择纯粉末（如果非要用的话）。

### 吲唑甲酰胺类

* [5F-AKB48](/药物/5F-AKB48.md)
* [AB-CHMINACA](/药物/AB-CHMINACA.md)
* [AB-FUBINACA](/药物/AB-FUBINACA.md)

### 吲哚甲酰胺类

* [APICA](/药物/APICA.md)
* [STS-135](/药物/STS-135.md)
* [MDMB-CHMICA](/药物/MDMB-CHMICA.md)

### 吲哚羧酸酯类

* [5F-PB-22](/药物/5F-PB-22.md)
* [BB-22](/药物/BB-22.md)

### 萘甲酰吲哚类

* [AM-2201](/药物/AM-2201.md)
* [JWH-018](/药物/JWH-018.md)
* [JWH-073](/药物/JWH-073.md)
* [JWH-122](/药物/JWH-122.md)

### 萘甲酰吲唑类

* [THJ-018](/药物/THJ-018.md)
* [THJ-2201](/药物/THJ-2201.md)

### 四甲基环丙烷酰吲哚类

* [UR-144](/药物/UR-144.md)
* [5F-UR-144](/药物/5F-UR-144.md)

### 综合列表

关于已知合成大麻素衍生物的综合列表，[/r/Drugs/wiki](https://www.reddit.com/r/Drugs/wiki/cannabinoids) 发布了一个相当不错的名称目录和更多信息的链接哦。

毒性和危害潜能
---------------------------

与[大麻](/药物/大麻.md)不同，重复滥用合成大麻素已与多起死亡事件相关联[\[4\]](#cite_note-death1-4)[\[5\]](#cite_note-death2-5)[\[6\]](#cite_note-death3-6)[\[7\]](#cite_note-death4-7)[\[8\]](#cite_note-death5-8)[\[9\]](#cite_note-death6-9)[\[10\]](#cite_note-death7-10)，长期使用还会导致严重的副作用呢[\[11\]](#cite_note-11)[\[12\]](#cite_note-12)[\[13\]](#cite_note-13)。因此，强烈不建议长时间或过量服用这种物质。与大麻及其活性大麻素 THC 相比，不良反应通常要严重得多，可能包括[血压升高](/药效/血压升高.md)、[心率增快](/药效/心率增快.md)、心脏病发作[\[14\]](#cite_note-14)[\[15\]](#cite_note-15)、激越[\[16\]](#cite_note-teen-16)、[呕吐](/药效/呕吐.md)[\[17\]](#cite_note-17)[\[18\]](#cite_note-18)[\[19\]](#cite_note-19)、[幻觉](/药效/外部幻觉.md)[\[20\]](#cite_note-20)、[精神病发作](/药效/精神病发作.md)[\[21\]](#cite_note-21)[\[22\]](#cite_note-british-22)[\[16\]](#cite_note-teen-16)[\[23\]](#cite_note-muller-23)、[癫痫发作](/药效/癫痫发作.md)[\[24\]](#cite_note-24)[\[25\]](#cite_note-25)[\[26\]](#cite_note-26)和惊厥[\[27\]](#cite_note-27)[\[28\]](#cite_note-28)等等。已有 16 例因滥用合成大麻素导致急性肾损伤的报告[\[29\]](#cite_note-29)。[JWH-018](/药物/JWH-018.md) 还与两名健康成年人的中风有关呢[\[30\]](#cite_note-30)。

需要注意的是，预先混合的品牌混合物（如 Spice 和 K2）比纯粉末更危险，因为具体的化学成分和剂量通常没有列出，而且粉末密度不均可能导致局部浓度过高，从而引发[药物过量](/文档/药物过量.md)。由于合成大麻素在毫克级别就有效（通常剂量低于 5mg），在[给药](/文档/给药剂量.md)时采取适当的预防措施以避免负面体验是非常重要的哦。

与使用大麻相比，这些更严重的不良反应被认为源于许多合成大麻素是大麻素受体 CB1R 和 CB2R 的[完全激动剂](/文档/受体激动剂.md)，而 THC 只是部分激动剂，因此无论剂量和浓度如何，都无法饱和并激活所有受体群[\[31\]](#cite_note-31)。

强烈建议在使用这些药物时采取[伤害减少措施](/文档/负责任的用药索引页.md)呢。

### 死亡案例

与[大麻](/药物/大麻.md)不同，长期滥用合成大麻素已与多起死亡事件相关联[\[4\]](#cite_note-death1-4)[\[5\]](#cite_note-death2-5)。

*   [MDMB-FUBINACA](/药物/MDMB-FUBINACA.md)：已有大量关于此合成大麻素的死亡和住院报告，主要在俄罗斯和白俄罗斯。MDMB-FUBINACA 于 2014 年首次被报道，到 2015 年迅速以最致命的合成大麻素药物而闻名[\[32\]](#cite_note-32)。媒体和政府报告最初将多达 700 例住院和 25 例死亡与 MDMB-FUBINACA 联系起来，随后的检测证实，截至 2015 年 3 月，至少有 1000 例住院和 40 例死亡是由于 MDMB-FUBINACA 中毒造成的[\[33\]](#cite_note-33)[\[34\]](#cite_note-34)。
*   [MDMB-CHMICA](/药物/MDMB-CHMICA.md)：2014 年至 2016 年间，在九个欧洲国家发生的 71 起严重不良事件，包括 42 起急性中毒和 29 起死亡（德国 5 起、匈牙利 3 起、波兰 1 起、瑞典 9 起、英国 10 起、挪威 1 起）与 MDMB-CHMICA 有关[\[35\]](#cite_note-EMCDDA-35)[\[36\]](#cite_note-36)[\[37\]](#cite_note-37)[\[38\]](#cite_note-38)[\[39\]](#cite_note-39)。
*   5F-MDMB-PINACA 在 2015 年至 2017 年间与欧洲的 25 起死亡事件有关[\[40\]](#cite_note-40)。
*   [5F-PB-22](/药物/5F-PB-22.md)：此外，在美国有 5 起死亡事件与使用 [5F-PB-22](/药物/5F-PB-22.md) 有关[\[7\]](#cite_note-death4-7)。
*   [AB-FUBINACA](/药物/AB-FUBINACA.md) 也因其使用导致了多起住院和死亡事件[\[10\]](#cite_note-death7-10)。

### 精神病

像 [THC](/药物/四氢大麻酚（THC）.md) 一样，长期使用合成[大麻素](/文档/药物分类/合成大麻素类物质.md)可能会增加患精神疾病和精神病的倾向[\[22\]](#cite_note-british-22)，特别是对于那些有精神病风险因素的脆弱个体（如精神分裂症既往史或家族史）[\[41\]](#cite_note-41)[\[42\]](#cite_note-42)[\[16\]](#cite_note-teen-16)。建议有精神障碍风险因素的人不要使用合成大麻素哦[\[43\]](#cite_note-43)。

与大多数其他娱乐性药物相比，据报道，使用合成大麻素引发的剧烈精神病状态在多起病例中持续了数周，在一个病例中，甚至在完全停止药物使用后持续了七个月[\[44\]](#cite_note-44)。有人认为，缺乏抗精神病化学物质（天然大麻中发现的[大麻二酚](/药物/大麻二酚（CBD）.md)）可能使合成大麻比天然大麻更容易诱发精神病[\[23\]](#cite_note-muller-23)。与急性身体不良反应一样，这种精神病副作用风险的增加也与完全激动作用而非部分激动作用有关[\[45\]](#cite_note-45)。

### 毒性

虽然目前还没有关于合成大麻素毒性的有效数据，但令人担忧的是，在 THJ-018 和其他一些[合成大麻素](/文档/药物分类/合成大麻素类物质.md)中发现的萘基团可能具有毒性或致癌性呢[\[46\]](#cite_note-46)[\[47\]](#cite_note-47)[\[48\]](#cite_note-48)[\[49\]](#cite_note-49)。

### 成瘾潜能

与[大麻](/药物/大麻.md)相比，长期使用合成大麻素可被认为具有中等成瘾性，且滥用潜力较高，并可能在某些使用者中引起心理依赖。当成瘾形成后，如果一个人突然停止使用，可能会出现渴求和[戒断反应](/文档/药物戒断反应.md)[\[50\]](#cite_note-50)。

### 危险的相互作用

***警告：*** *许多精神活性物质单独使用时相对安全，但与某些其他物质结合使用时，可能会突然变得危险甚至危及生命。以下列表列出了一些已知的危险相互作用（尽管不保证包含所有相互作用）。*

*在混合两种或多种物质之前，请务必进行独立研究（例如使用 [Google](https://www.google.com)、[DuckDuckGo](https://www.duckduckgo.com)、[PubMed](https://pubmed.ncbi.nlm.nih.gov/)）以确保安全。部分列出的相互作用来自 [TripSit](https://combo.tripsit.me)。*

*   **[2C-T-x](/文档/药物分类/2C-T-x.md)**
*   **[2C-x](/文档/药物分类/2C-x.md)**
*   **[5-MeO-xxT](/药物/5-MeO-xxT.md)**
*   **[苯丙胺类物质](/文档/药物分类/苯丙胺类物质.md)** - 兴奋剂会增加焦虑水平和思维循环的风险，这可能导致负面体验呢。
*   **[aMT](/药物/αMT.md)**
*   **[可卡因](/药物/可卡因.md)** - 兴奋剂会增加焦虑水平和思维循环的风险，这可能导致负面体验。
*   **[DMT](/药物/DMT.md)**
*   **[DOx](/文档/药物分类/DOx.md)**
*   **[锂盐](/药物/锂盐.md)** - 锂盐通常用于治疗双相情感障碍；然而，大量的轶事证据表明，将其与大麻素一起服用会显着增加[精神病发作](/药效/精神病发作.md)和[癫痫发作](/药效/癫痫发作.md)的风险。因此，应严格避免这种组合！⛔
*   **[LSD](/药物/LSD.md)**
*   **[麦斯卡林](/药物/麦斯卡林.md)**
*   **[赛洛西宾蘑菇](/药物/赛洛西宾蘑菇.md)**
*   **[25x-NBOMe](/文档/药物分类/25x-NBOMe.md)**

另见
--------

*   [负责任的用药](/文档/负责任的用药索引页.md)
*   [研究用化学品](/文档/研究用化学品.md)
*   [大麻](/药物/大麻.md)
*   [大麻素类](/文档/药物分类/大麻类.md)
*   [AB-FUBINACA](/药物/AB-FUBINACA.md)
*   [THJ-2201](/药物/THJ-2201.md)
*   [JWH-018](/药物/JWH-018.md)

外部链接
--------------

*   [Synthetic cannabinoids (Wikipedia)](https://en.wikipedia.org/wiki/Synthetic_cannabinoids)
*   [Cannabinoids & Synthetic Cannabinoids (Erowid Vault)](https://erowid.org/chemicals/cannabinoids/cannabinoids.shtml)
*   [Spice-Like Products (Erowid Vault)](https://www.erowid.org/chemicals/spice_product/)

参考文献
----------

1.  [↑](#cite_ref-1) [*Synthetic Marijuana*](https://leb.fbi.gov/articles/featured-articles/synthetic-marijuana)
2.  [↑](#cite_ref-2) Carmichael, M. (2010), [*K2: Scary Drug or Another Drug Scare?*](https://www.newsweek.com/k2-scary-drug-or-another-drug-scare-69177)
3.  [↑](#cite_ref-3) "What's the buzz?: Synthetic marijuana, K2, Spice, JWH-018 : Terra Sigillata". Scienceblogs.com. | <http://scienceblogs.com/terrasig/2010/02/09/k2-spice-jwh018-marijuana/>
4.  ↑ [4.0](#cite_ref-death1_4-0) [4.1](#cite_ref-death1_4-1) Brents, L. K., Reichard, E. E., Zimmerman, S. M., Moran, J. H., Fantegrossi, W. E., Prather, P. L. (2011). "Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity". *PloS One*. **6** (7): e21917. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1371/journal.pone.0021917](//doi.org/10.1371%2Fjournal.pone.0021917). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1932-6203](//www.worldcat.org/issn/1932-6203).
5.  ↑ [5.0](#cite_ref-death2_5-0) [5.1](#cite_ref-death2_5-1) [*Coroner: Lamar Jack ingested chemical found in fake marijuana before he died » Anderson Independent Mail*](https://web.archive.org/web/20131009101212/http://www.independentmail.com/news/2011/oct/15/coroner-lamar-jack-ingested-chemical-found-fake-ma/), 2013
6.  [↑](#cite_ref-death3_6-0) [*Colorado probes three deaths possibly linked to synthetic marijuana*](https://www.reuters.com/article/us-usa-colorado-spice-idUSBRE98516A20130906), 2013
7.  ↑ [7.0](#cite_ref-death4_7-0) [7.1](#cite_ref-death4_7-1) [*Synthetic cannabinoids in Europe*](https://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids)
8.  [↑](#cite_ref-death5_8-0) Westin, A. A., Frost, J., Brede, W. R., Gundersen, P. O. M., Einvik, S., Aarset, H., Slørdal, L. (9 September 2015). ["Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA"](https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkv110). *Journal of Analytical Toxicology*: bkv110. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1093/jat/bkv110](//doi.org/10.1093%2Fjat%2Fbkv110). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0146-4760](//www.worldcat.org/issn/0146-4760).
9.  [↑](#cite_ref-death6_9-0) Adamowicz, P. (April 2016). ["Fatal intoxication with synthetic cannabinoid MDMB-CHMICA"](https://linkinghub.elsevier.com/retrieve/pii/S0379073816300469). *Forensic Science International*. **261**: e5–e10. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.forsciint.2016.02.024](//doi.org/10.1016%2Fj.forsciint.2016.02.024). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0379-0738](//www.worldcat.org/issn/0379-0738).
10. ↑ [10.0](#cite_ref-death7_10-0) [10.1](#cite_ref-death7_10-1) Trecki, J., Gerona, R. R., Schwartz, M. D. (9 July 2015). ["Synthetic Cannabinoid–Related Illnesses and Deaths"](https://doi.org/10.1056/NEJMp1505328). *New England Journal of Medicine*. **373** (2): 103–107. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1056/NEJMp1505328](//doi.org/10.1056%2FNEJMp1505328). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0028-4793](//www.worldcat.org/issn/0028-4793).
11. [↑](#cite_ref-11) Vardakou, I., Pistos, C., Spiliopoulou, C. (1 September 2010). "Spice drugs as a new trend: mode of action, identification and legislation". *Toxicology Letters*. **197** (3): 157–162. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.toxlet.2010.06.002](//doi.org/10.1016%2Fj.toxlet.2010.06.002). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1879-3169](//www.worldcat.org/issn/1879-3169).
12. [↑](#cite_ref-12) Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., Ferreirós, N. (May 2009). ["'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?"](https://onlinelibrary.wiley.com/doi/10.1002/jms.1558). *Journal of Mass Spectrometry*. **44** (5): 832–837. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1002/jms.1558](//doi.org/10.1002%2Fjms.1558). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1076-5174](//www.worldcat.org/issn/1076-5174).
13. [↑](#cite_ref-13) Kronstrand, R., Roman, M., Andersson, M., Eklund, A. (1 October 2013). ["Toxicological Findings of Synthetic Cannabinoids in Recreational Users"](https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkt068). *Journal of Analytical Toxicology*. **37** (8): 534–541. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1093/jat/bkt068](//doi.org/10.1093%2Fjat%2Fbkt068). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0146-4760](//www.worldcat.org/issn/0146-4760).
14. [↑](#cite_ref-14) Mir, A., Obafemi, A., Young, A., Kane, C. (1 December 2011). ["Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2"](https://publications.aap.org/pediatrics/article/128/6/e1622/31047/Myocardial-Infarction-Associated-With-Use-of-the). *Pediatrics*. **128** (6): e1622–e1627. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1542/peds.2010-3823](//doi.org/10.1542%2Fpeds.2010-3823). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0031-4005](//www.worldcat.org/issn/0031-4005).
15. [↑](#cite_ref-15) McIlroy, G., Ford, L., Khan, J. M. (16 January 2016). ["Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715335/). *BMC Pharmacology & Toxicology*. **17**: 2. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1186/s40360-016-0045-1](//doi.org/10.1186%2Fs40360-016-0045-1). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [2050-6511](//www.worldcat.org/issn/2050-6511).
16. ↑ [16.0](#cite_ref-teen_16-0) [16.1](#cite_ref-teen_16-1) [16.2](#cite_ref-teen_16-2) Vearrier, D., Osterhoudt, K. C. (June 2010). ["A Teenager With Agitation: Higher Than She Should Have Climbed"](http://journals.lww.com/00006565-201006000-00016). *Pediatric Emergency Care*. **26** (6): 462–465. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1097/PEC.0b013e3181e4f416](//doi.org/10.1097%2FPEC.0b013e3181e4f416). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0749-5161](//www.worldcat.org/issn/0749-5161).
17. [↑](#cite_ref-17) [*JWH-018 - Erowid Exp - “Extreme Nausea, Incoherent”*](https://www.erowid.org/experiences/exp.php?ID=84443)
18. [↑](#cite_ref-18) [*Spice - Erowid Exp - “Playing With Fire”*](https://www.erowid.org/experiences/exp.php?ID=90178)
19. [↑](#cite_ref-19) [*Spice and Synthetic Cannabinoids ('Drill’) - Erowid Exp - “Non-Allergic Adverse Reaction”*](https://www.erowid.org/experiences/exp.php?ID=85853)
20. [↑](#cite_ref-20) published, J. B. (2010), [*Fake Weed, Real Drug: K2 Causing Hallucinations in Teens*](https://www.livescience.com/6149-fake-weed-real-drug-k2-causing-hallucinations-teens.html)
21. [↑](#cite_ref-21) Every-Palmer, S. (October 2010). "Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals". *Addiction (Abingdon, England)*. **105** (10): 1859–1860. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1111/j.1360-0443.2010.03119.x](//doi.org/10.1111%2Fj.1360-0443.2010.03119.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1360-0443](//www.worldcat.org/issn/1360-0443).
22. ↑ [22.0](#cite_ref-british_22-0) [22.1](#cite_ref-british_22-1) Arseneault, L., Cannon, M., Witton, J., Murray, R. M. (February 2004). ["Causal association between cannabis and psychosis: examination of the evidence"](https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/causal-association-between-cannabis-and-psychosis-examination-of-the-evidence/71BA37D16485F186CE7B6B785E5B69A4). *The British Journal of Psychiatry*. **184** (2): 110–117. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1192/bjp.184.2.110](//doi.org/10.1192%2Fbjp.184.2.110). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0007-1250](//www.worldcat.org/issn/0007-1250).
23. ↑ [23.0](#cite_ref-muller_23-0) [23.1](#cite_ref-muller_23-1) Müller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., Maler, J.-M. (May 2010). "The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes". *Schizophrenia Research*. **118** (1–3): 309–310. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.schres.2009.12.001](//doi.org/10.1016%2Fj.schres.2009.12.001). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1573-2509](//www.worldcat.org/issn/1573-2509).
24. [↑](#cite_ref-24) [*JWH-018 - Erowid Exp - “Most Insane Hour of My Life”*](https://www.erowid.org/experiences/exp.php?ID=85936)
25. [↑](#cite_ref-25) [*AM-2201 - Erowid Exp - “The Night My Brain Caved”*](https://www.erowid.org/experiences/exp.php?ID=92954)
26. [↑](#cite_ref-26) [*Products - Spice and Synthetic Cannabinoids (“Apocalypse”?) - Erowid Exp - “Next-Night Seizures”*](https://www.erowid.org/experiences/exp.php?ID=89290)
27. [↑](#cite_ref-27) [*Products - Spice and Synthetic Cannabinoids ('Smiley Dog’) - Erowid Exp - “Never Again”*](https://www.erowid.org/experiences/exp.php?ID=88807)
28. [↑](#cite_ref-28) Schneir, A. B., Baumbacher, T. (March 2012). "Convulsions associated with the use of a synthetic cannabinoid product". *Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology*. **8** (1): 62–64. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1007/s13181-011-0182-2](//doi.org/10.1007%2Fs13181-011-0182-2). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1937-6995](//www.worldcat.org/issn/1937-6995).
29. [↑](#cite_ref-29) [*Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012*](https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6206a1.htm)
30. [↑](#cite_ref-30) Freeman, M. J., Rose, D. Z., Myers, M. A., Gooch, C. L., Bozeman, A. C., Burgin, W. S. (10 December 2013). "Ischemic stroke after use of the synthetic marijuana "spice"". *Neurology*. **81** (24): 2090–2093. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1212/01.wnl.0000437297.05570.a2](//doi.org/10.1212%2F01.wnl.0000437297.05570.a2). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1526-632X](//www.worldcat.org/issn/1526-632X).
31. [↑](#cite_ref-31) Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., Prather, P. L. (27 February 2014). "Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?". *Life Sciences*. **97** (1): 45–54. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.lfs.2013.09.017](//doi.org/10.1016%2Fj.lfs.2013.09.017). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1879-0631](//www.worldcat.org/issn/1879-0631).
32. [↑](#cite_ref-32) Shevyrin V, Melkozerov V, Nevero A, Eltsov O, Shafran Y, Morzherin Y, Lebedev AT (August 2015). "Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group". *Analytical and Bioanalytical Chemistry*. **407** (21): 6301–15. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1007/s00216-015-8612-7](//doi.org/10.1007%2Fs00216-015-8612-7). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [25893797](//www.ncbi.nlm.nih.gov/pubmed/25893797). Unknown parameter `|s2cid=` ignored ([help](/w/index.php?title=Help:CS1_errors&action=edit&redlink=1 "Help:CS1 errors (page does not exist)"))
33. [↑](#cite_ref-33) ["Выступление председателя ГАК, директора ФСКН России В.П. Иванова на заседании ГАК 6 октября 2014 г"](https://web.archive.org/web/20150709115330/http://fskn.gov.ru/includes/periodics/speeches_fskn/2014/1006/124332682/detail.shtml) (in Russian). Federal Drug Control Service of the Russian Federation. 6 October 2014. Archived from [the original](http://fskn.gov.ru/includes/periodics/speeches_fskn/2014/1006/124332682/detail.shtml) on 9 July 2015. Retrieved 24 June 2015. Unknown parameter `|url-status=` ignored ([help](/w/index.php?title=Help:CS1_errors&action=edit&redlink=1 "Help:CS1 errors (page does not exist)"))
34. [↑](#cite_ref-34) I. Bulygina (21 October 2014). ["Clinical presentations of intoxication by new psychoactive compound MDMB(N)-Bz-F. Thesis of The II Scientific and Practical Seminar 'Methodical, Organizational and Law Problems of Chemical and Toxicological Laboratories of Narcological Services', Moscow"](http://www.narkotiki.ru/objects/narkotiki02/1414709242.ppt) (in Russian). Retrieved 13 July 2015.
35. [↑](#cite_ref-EMCDDA_35-0) Cite error: Invalid `<ref>` tag; no text was provided for refs named `EMCDDA`
36. [↑](#cite_ref-36) ["Derby legal high confusion prompts police warning"](https://www.bbc.com/news/uk-england-derbyshire-32477643). BBC. 29 April 2015. Retrieved 29 June 2015.
37. [↑](#cite_ref-37) ["Drug Alert: Dangerous Synthetic Cannabinoid MMB-CHMINACA Causing Hospitalizations, Deaths in Europe"](http://www.talkingdrugs.org/drug-alert-dangerous-synthetic-cannabinoid-mmb-chminaca-causing-hospitalizations-deaths-in-europe). TalkingDrugs. 2 July 2015. Retrieved 2 July 2015.
38. [↑](#cite_ref-38) Westin AA, Frost J, Brede WR, Gundersen PO, Einvik S, Aarset H, Slørdal L (February 2016). "Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA". *Journal of Analytical Toxicology*. **40** (1): 86–7. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1093/jat/bkv110](//doi.org/10.1093%2Fjat%2Fbkv110) ![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [26353925](//www.ncbi.nlm.nih.gov/pubmed/26353925).
39. [↑](#cite_ref-39) Adamowicz P (April 2016). "Fatal intoxication with synthetic cannabinoid MDMB-CHMICA". *Forensic Science International*. **261**: e5–10. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.forsciint.2016.02.024](//doi.org/10.1016%2Fj.forsciint.2016.02.024). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [26934903](//www.ncbi.nlm.nih.gov/pubmed/26934903).
40. [↑](#cite_ref-40) [Template:Cite report](/w/index.php?title=Template:Cite_report&action=edit&redlink=1 "Template:Cite report (page does not exist)")
41. [↑](#cite_ref-41) Every-Palmer, S. (September 2011). ["Synthetic cannabinoid JWH-018 and psychosis: An explorative study"](https://linkinghub.elsevier.com/retrieve/pii/S0376871611000639). *Drug and Alcohol Dependence*. **117** (2–3): 152–157. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.drugalcdep.2011.01.012](//doi.org/10.1016%2Fj.drugalcdep.2011.01.012). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0376-8716](//www.worldcat.org/issn/0376-8716).
42. [↑](#cite_ref-42) Schneir, A. B., Cullen, J., Ly, B. T. (1 March 2011). [""Spice" Girls: Synthetic Cannabinoid Intoxication"](https://www.sciencedirect.com/science/article/pii/S0736467910008802). *The Journal of Emergency Medicine*. **40** (3): 296–299. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.jemermed.2010.10.014](//doi.org/10.1016%2Fj.jemermed.2010.10.014). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0736-4679](//www.worldcat.org/issn/0736-4679).
43. [↑](#cite_ref-43) Every-Palmer, S. (1 September 2011). "Synthetic cannabinoid JWH-018 and psychosis: an explorative study". *Drug and Alcohol Dependence*. **117** (2–3): 152–157. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.drugalcdep.2011.01.012](//doi.org/10.1016%2Fj.drugalcdep.2011.01.012). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1879-0046](//www.worldcat.org/issn/1879-0046).
44. [↑](#cite_ref-44) Hurst, D., Loeffler, G., McLay, R. (October 2011). "Psychosis associated with synthetic cannabinoid agonists: a case series". *The American Journal of Psychiatry*. **168** (10): 1119. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1176/appi.ajp.2011.11010176](//doi.org/10.1176%2Fappi.ajp.2011.11010176). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1535-7228](//www.worldcat.org/issn/1535-7228).
45. [↑](#cite_ref-45) Murray, R. M., Quigley, H., Quattrone, D., Englund, A., Di Forti, M. (October 2016). ["Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis"](https://onlinelibrary.wiley.com/doi/10.1002/wps.20341). *World Psychiatry*. **15** (3): 195–204. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1002/wps.20341](//doi.org/10.1002%2Fwps.20341). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1723-8617](//www.worldcat.org/issn/1723-8617).
46. [↑](#cite_ref-46) Naphthalene - United States Environmental Protection Agency | <http://www.epa.gov/ttn/atw/hlthef/naphthal.html>
47. [↑](#cite_ref-47) Lin, C. Y., Wheelock, A. M., Morin, D., Baldwin, R. M., Lee, M. G., Taff, A., Plopper, C., Buckpitt, A., Rohde, A. (16 June 2009). "Toxicity and metabolism of methylnaphthalenes: comparison with naphthalene and 1-nitronaphthalene". *Toxicology*. **260** (1–3): 16–27. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.tox.2009.03.002](//doi.org/10.1016%2Fj.tox.2009.03.002). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1879-3185](//www.worldcat.org/issn/1879-3185).
48. [↑](#cite_ref-48) Synthetic cannabinoids in herbal products (United Nations Office on Drugs and Crime) | <https://www.unodc.org/documents/scientific/Synthetic_Cannabinoids.pdf>
49. [↑](#cite_ref-49) Morris, H. (2010), [*HAMILTON MORRIS?: NAPTHALENE IS SO OVER*](http://hamiltonmorris.blogspot.com/2010/06/napthalene-is-so-over.html)
50. [↑](#cite_ref-50) Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., Schulz, K. (July 2009). ["Withdrawal Phenomena and Dependence Syndrome After the Consumption of "Spice Gold""](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719097/). *Deutsches Ärzteblatt International*. **106** (27): 464–467. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.3238/arztebl.2009.0464](//doi.org/10.3238%2Farztebl.2009.0464). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1866-0452](//www.worldcat.org/issn/1866-0452).